AMGN vs IDXX · P/E 24, rev $10.05B vs P/E 40, rev $2.36B
Amgen Inc (AMGN) versus IDEXX Laboratories Inc (IDXX) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
IDEXX Laboratories Inc (IDXX) is a diagnostics & research company listed on NASDAQ.
Latest reported AMGN revenue for 2026-06-30 was $10.05B. Net income was $2.38B. Revenue was up 16.7% from 2026-03-31 to 2026-06-30. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported IDXX revenue for 2026-06-30 was $2.36B. Net income was $616.9M. IDXX currently screens at market cap $43.08B and trailing P/E 40.2.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. IDXX currently screens at market cap $43.08B and trailing P/E 40.2.
Not investment advice. Open the AMGN and IDXX stock pages for the full models.
Not investment advice.